FORUM VIDEOS
ROUNDTABLE IA
Funding Innovation
New Trends in the Healthcare M&A Landscape
(Co-sponsored by Biopharm Insight, part of the Financial Times Group and by Proskauer)
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
| Kimberly Ha, Global Editor, Biopharm Insight | Hunt Henrie | Paul I. Rachlin, Partner, Proskauer | Les Funtleyder, MPH, Healthcare Strategist and Portfolio Manager, Miller Tabak Health Care Transformation Fund | Jonathan Silverstein, Partner, OrbiMed Advisors | Jide Zeitlan, CEO, Keffi Group |
ROUNDTABLE IB
What is "Value" and How Can it be Measured and Demonstrated in Therapeutic Innovations?
Breaking Down the Barriers of the Past
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
| Richard C. Pasternak, MD, former Merck & Co., Inc vice president. and past director, Preventive Cardiology Massachusetts General Hospital and Harvard Medical School associate professor | Peter J. Pitts, President, Center for Medicine in the Public Interest | Roger Longman, CEO, Real Endpoints | Jeffery Berkowitz, SVP Pharmaceutical Development and Market Access at Walgreens | Barry Gertz, MD, PhD., SVP at Merck, and head of clinical research and regulatory affairs | Robert S. Epstein M.D., Chief Clinical Research and Development Officer, Medco Health Solutions, Inc. |
ROUNDTABLE IIA
The Next Generation of Health and Research Informatics
Accelerating Translational Research & Personalized Medicine at Moffitt Cancer Center
(Sponsored by Oracle)
![]() |
![]() |
![]() |
![]() |
| Brett Davis, Senior Director, Personalized Healthcare, Oracle Corporation, Health Sciences Global Business Unit | Robert M. Wenham, MD, MS, FACOG, FACS,
Principal Investigator, Total Cancer Care Programs of Gynecologic Oncology & Experimental
Therapeutics Moffitt Cancer Center |
Dana Rollison, Ph.D., Vice President, Total Cancer Care and Chief Health Information Officer, Moffitt Cancer Center | Mark Hulse, RN, Vice President Information Technology and Chief Information Officer, Moffitt Cancer Center and Dana Rollison |
|
Part 1: Brett Davis Part 2: Robert M. Wenham Part 3: Dana Rollison |
Part 4: Mark Hulse and Dana Rollison Part 5: Brett Davis, Mark Hulse, Dana Rollison and Robert M. Wenham |
ROUNDTABLE IIB
A Global Health Challenge: The Obesity and Diabetes Epidemic
Where are the Innovations and Who Will Pay For Them?
(Sponsored by Alexandria Real Estate Equities, Inc.)
![]() |
![]() |
![]() |
![]() |
| Lynne Zydowsky, PhD, President, Zydowsky Consultants | Ron Winslow, Senior Medical and Health Care Writer, WSJ Deputy Editor, Health and Science | Francesco Rubino, MD, Associate Professor of Surgery, Director, Metabolic & Diabetes Surgery Center, Weill Cornell Medical College | Stephen Daniels, MD, PhD, MPH, Professor and Chair, Department of Pediatrics, University of Colorado School of Medicine, Pediatrician-in-Chief , L Joseph, Butterfield Chair in Pediatrics, Children's Hospital Colorado |
![]() |
![]() |
![]() |
![]() |
| Martin Fitchet, MD, Chief Operating Officer, Johnson & Johnson, Pharmaceutical Research & Development | Magnus Persson, MD, PhD, Managing Partner, The Column Group | Alex DePaoli, MD, Vice President of Translational Research, NGM Biopharmaceuticals | Jeffrey Friedman, MD, PhD, Marilyn M Simpson Professor, Investigator Howard Hughes Medical Institute, Laboratory of Genetics, The Rockefeller University |
ROUNDTABLE IIC
Perspectives on Innovation, Patient Safety and Global Access
Thinking Beyond Laboratories and Clinical Trials
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
| Michael Rosenblatt, MD, Executive Vice President and Chief Medical Officer, Merck & Co., Inc. | Larry Norton, MD, Deputy physician-in-chief for breast cancer programs and medical director, Evelyn H. Lauder Breast Center, Memorial Sloan-Kettering Cancer Center | Peter D. Loftus, Dow Jones Newswires reporter covering pharmaceutical industry; contributor to Wall Street Journal | Steven Nissen, M.D., M.A.C.C., Chairman, Department of Cardiovascular Medicine Cleveland Clinic Foundation and Professor of Medicine, Cleveland Clinic Lerner School of Medicine at Case Western Reserve U. | Mark Pykett, President and Chief Executive Officer, Neoprobe Corporation | Kevin Tabb, MD, chief medical officer, Stanford Hospital & Clinics. |
2nd Galien Forum Photos
![]() |
![]() |
![]() |
| Prix Galien USA Register Submission Guidelines and form The Committee Committee Charter |
Galien Forum Register Program |
Galien Foundation About Us Calendar Press Room Contact |